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Abstract
This paper includes the determination homocysteine level and trace elements magnesium (Mg), 
zinc (Zn)and iron (Fe) in ppm (part per million); lead (Pb), cadmium (Cd ), selenium (Se ), chro-
mium (Cr ) and germanium (Ge ) in ppb (part per billion)) in random serum of patients with 
pure ischemia, ischemia with hypertension and ischemia with diabetes. Homocysteine level was 
significantly increased ( P< 0.01)   in pure ischemic patients, ischemia with hypertension and 
ischemia with diabetes in comparison with control group. A comparison had also been done be-
tween male & female groups in patients and control groups and no significant changes (P >0.05)
were observed. The result of this study showed that concentration of the trace elements (Pb& 
Cd ) were significantly increased (P< 0.01)  in patients groups in comparison with control group 
and the concentration of (Mg ,Zn, Se, Cr and Ge) were significantly decreased (P< 0.01)  among 
patients groups in comparison with control group.
Keywords: Homocysteine, High performance liquid chromrtography, Trace elements ,Atomic 
absorption spectrography. Ischemic heart disease .
1. Introduction 
Homocysteine (Hcy) is an intermediate of methionine metabolism [1]. Elevated blood homocys-
teine concentration was an independent risk factor for cardiovascular disease [1, 2]. High-normal 
serum homocysteine concentrations are associated with an increased prevalence of carotid artery 
wall thickening [3] . The significance of the contribution of homocysteine to the variation of ca-
rotid intima-media thickness suggests a role for homocysteine as an independent risk factor for 
early carotid artery atherosclerosis in the asymptomatic subjects. Different studies indicated that 
the elevated level of total homocysteine (tHcy) had increased the risk of cardiovascular diseases 
and stroke [4]. Homocysteine is elevated in the case of inborn errors of methionine metabolism 
and excessive amount of homocysteine and its derivatives are found in blood and tissues of car-
diovascular patients [5].  Moderate hyperhomocysteinemia up to (30 µmol/l ) is a major indepen-
dent risk  factor of a number of diseases characteristic of old ages , primarily occlusive  vascular 
disease [6].  Non metallic elements (hydrogen, oxygen, carbon and nitrogen) make 99% of all the 
elements in human body, while major elements, which are calcium, magnesium, phosphorus, 
sulfur and chlorine, make 0.9% of the total. However, essential trace elements provide approxi-
mately less than 0.1% of human body [7]. Trace metals are metals in extremely small quantities, 
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almost at the molecular level, that reside in or are present in animal and plant cells and tissue. 
Trace metals are a group of metals that include both heavy and transitional elements present in 
micrograms quantities in the blood. There are divided into two groups, essential for health and 
have no known biological function. 
 In human body, there are some metals which naturally exist and are essential to human health. 
These essential metals at trace levels play vital role when present in human body and may cause 
some diseases when present beyond specific concentrations [8, 9].  
2. Designing  
MATERIALS AND METHODES
Patients: The study was conducted during the period from Augest, 2008 to May , 2009 in Merjan 
hospital in Hilla city , Babylon province, Iraq.  A total 57 patients were included from urban and 
rural area(35 males and 22 females) (Table 3-1). Twenty three patients had pure ischemic heart 
disease (17 males and 6 females), 18 had ischemic heart disease with hypertension  (10 males and 
6 females),18 had ischemia heart disease with diabetes (8 males and 10 females ). The age of the 
patients  varying between 40-85 years old (mean± SD 57.82±10.25). 
Control Group: The control group consisted of 40 healthy person who were chosen as healthy, 
non smokers , didn’t have any history of chronic disease and didn’t take any treatment for chron-
ic diseases
3. Results
The patients and control were divided according to ages into two groups group 1  in which the 
age range between 40-60 year and age group two in which the age is > 60 year as shows in table 1.
Age
Patients
60 year<40- 60 year
1211Pure ischemia
Isc
he
mi
c 
pa
tie
nts
1214Ischemia with hypertension
108Ischemia with diabetes
16124Control
Table 1. Patients and control number according to age group
The sex distribution of total ischemic patients,  was clearly obvious . The highest percentage in 
male was 61% while female  was 39% ( figure 1). 
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Figure 1. Sex distribution of total ischemic patients.
Table 2 show the sex distribution for all patients in this study. Number of female patients in isch-
emia with diabetes was more than male patients while in ischemia and ischemia with hyperten-
sion male patients were more than female.
Groups
Number
Male % Female %
Pa
tie
nts
Pure ischemic patients 17 31 6 14
Ischemic patients with hypertension 10 18 6 14
Ischemic patients with diabetes 8 15 10 24
Control 20 36 20 48
Total 55 42
Table 2. Sex distribution in the study groups
Comparison between ischemic male or female  and similar sex  healthy controls results indicate 
an increase in level of homocysteine among patients groups. This elevation in homocysteine con-
centration value was highly significant (P < 0.01). When similar comparisons were  done between 
ischemia with hypertension and ischemia with diabetes   and control group a similar behavior 
were observed (P < 0.01).Table 3 shows the mean values of serum level of homocysteine in male 
and female compared with the mean values in control group. No significant changes was ob-
served when comparison was done between two age groups as shown in table 4.   
Female
Mean ± SD
Male
Mean ± SD
 Groups
9.11±0.659.58 ±0.93Control
25.4**±2.524.11**±5.45Ischemic patients
23.9**±4.8520.84**±3.38Ischemia with hypertension
21.26**±1.44± 22.16**±3.59Ischemia with diabetic
    ** P < 0.01
Table 3. The mean serum level of homocysteine in male and female patients groups and control group
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Age group Pure ischemia
Ischemia with  
hypertension 
Ischemia with diabetes
40-60 23.29±5.3 19.83 ± 1.81 24 ± 4.62
> 60 25.32 ±4.93 22.88 ±4.87 21.02 ±1.23
Table 4. Comparison of levels of homocysteine (µmol/l) between two age groups ( age group 1 (40-60) and 
age group 2 (>60))
There is a highly significant increase in homocysteine level in ischemic patients compared with 
control values (P < 0.01).Also there is significant increase in homocysteine level in patients with 
ischemia with hypertension & ischemia with diabetes compared with control patients as shown 
in table 5.
Mean
µg/ml±SD
Groups
9.35±0.82Control
24.31 **±5.09Ischemic patients
22.46**±4.61Ischemia with hypertension
21.84**±2.96Ischemia with diabetic
  ** P < 0.01
Table 5. The mean serum level of homocysteine( µmol/l) in different patients groups and control groups
There is no significant changes in serum homocysteine level between pure ischemic patients , 
ischemia with hypertension and ischemia with diabetes ( P >0.05).
Measurements of trace elements in serum of two age groups (40-60) and > 60 years shows no sig-
nificant changes in their levels  (p > 0.05).Table 6 shows  comparison of trace metal concentration 
in control group between two age groups 
Trace elements
Concentration ( mean ± SD )
Age groups of 40- 60 year Age groups of >60 years
µg
/ m
l Mg 19.6±1.47 19.59±1.84
Zn 1.04 ±0.37 1.03±0.13
Fe 1.06±0.18 1.05±0.13
ng
  /m
l
Pb 0.09±0.15 0.12±0.19
Cd 0.00 0.00
Se 102.65±18.03 103.75±10.05
Cr 55.22±6.79 55.98±6.17
Ge 42.43±4.41 41.54±4.18
Table 6. Comparison of trace metal concentration  in control group between two age groups
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Measurements of trace elements in   two age groups (40-60) and > 60 years in all patients groups 
shows no significant changes in their levels  (p > 0.05 ) as shown in table 7 .
Age 
groups
Pure ischemia Ischemia with hypertension Ischemia with diabetes
Mg Zn Fe Mg Zn Fe Mg Zn Fe
40-60 14.43±2.33
0.73
±0.17
1.5
±1.77
14.25
±1.08
0.73
±0.11
1.01
±0.13
17.9
±3.73
0.95
±0.23
0.94
±0.19
>60
14.32
±3.03
0.6
±0.12
1.15
±0.76
14.5
±1.36
0.68
±0.2
1.41
±1.23
13.14
±1.95
0.68
±0.24
0.96
±0.19
All ages 14.38±2.46
0.66
±0.16
1.33
±1.36
14.43
± 1.27
0.96
±0.18
1.3
±1.06
15.26
±3.66
0.8
±0.26
0.95
±0.18
Table 7. Comparison of levels of (Mg , Zn and Fe  ) between two age groups { age group 1 (40-60 year) and 
age group 2 (>60 year)}.
Trace elements level:
There is a significant decrease in the level of magnesium, zinc ,selenium , chromium & germani-
um in all patients groups in comparism with control group (P < 0.01) & significant increase level 
of both lead & cadmium in all patients group than that of control group (P < 0.01) while there is 
no significant changes in the level  of iron (p< 0.5) as shown in table  8.
Ischemia with 
diabetes
Ischemia with 
hypertension 
Pure ischemiaControl
Trace  
elements
15.25±3.66**14.44±1.27**14.38±2.64**19.59±1.58Mg
g/
ml
μ
0.8±0.26**0.68±0.18**0.66±0.15**1.16±0.22Zn
0.95±0.191.30±1.061.33±1.361.06±0.18Fe
3.58**±1.065.63**±1.736.39**±2.890.11±0.17Pd
ng
/ m
l 4.89**±1.754.78**±1.835.07**±2.690.00±0.00Cd
61.81**±7.1961.53**±11.1753.37**±14.85103.64±11.95Se
31.02**±3.2132.05**±11.7732.42**±6.9555.21±6.93Cr
14.61**± 616.9**±5.1918.51**±6.1442.37± 4.76Ge
Table 8. Trace elements level in control & patients groups. ** (P < 0.01)
4. Discssion
The relationship between increased homocysteine and heart disease is well established in the 
medical community. Unlike the other three predictors of heart disease which are cholesterol, tri-
glycerides and C Reactive Protein, homocysteine levels are influenced by what the person does 
not eat rather than what he does eat. This is due to the fact that homocysteine is a sulphydryl-
containing amino acid derived from demethylation of methionine. Nutritional deficiencies in the 
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vitamin cofactors (folate, vitamin B12, and vitamin B6) required for homocysteine metabolism 
may promote hyperhomocysteinaemia [10]. This means that increased homocysteine levels are 
associated with increased risk of cardiovascular disease and then  tHcy measurement will be-
come another useful marker of vascular risk, multivitamin therapy will be another therapeutic 
option for people at risk of atherothrombotic vascular disease, and fortification of food with folic 
acid will rise high on the political and public health agenda. Homocysteine level in all patients 
with heart disease in this study (  pure ischemia, ischemia with hypertension and ischemia with 
diabetes ) were found to be elevated significantly(P < 0.01) compared with control groups.    Only 
about two-thirds of all episodes of symptomatic atherothrombotic vascular disease in developed 
countries can be attributed to established genetic and environmental vascular risk factors [11]. 
An additional causal vascular risk factor may be raised plasma levels of homocysteine (hyper-
homocysteinaemia).
Mild hyperhomocysteinaemia occurs in approximately 6% of the general population [12,13 ]. 
Patients with mild hyperhomocysteinaemia are typically asymptomatic until the third or fourth 
decade of life when premature coronary artery disease develops, as well as recurrent arterial and 
venous thrombosis.The elevation of serum level of homocysteine (hyperhomocysteinemia) in 
this study could be  considered as a risk factor for cardiovascular disease. Research has shown 
that increased homocysteine level  is associated with both the hyperinsulinemia seen with insu-
lin resistance and increased urinary albumin excretion. It is also associated with low serum levels 
of vitamin B12 [14]. However, supplementation with vitamin B12 has resulted in reduction of 
homocysteine levels, but as failed to show subsequent reductions in incidence of cardiovascular 
disease [15].  Trace elements are micro-nutrients, present in blood and tissues. They are essential 
for enzymatic activities and metabolic processes and even for vital functions [16 , 17]  . Some trace 
metals have antiviral activity, while others may alter the genome of the viruses enhancing their 
virulence [18].  Several trace elements are of great importance in a number of biological processes, 
mostly through the following terms:
1- Their action as activators or inhibitors of enzymatic reactions,
2- Competing with other elements and proteins for binding sites,
 3- Influencing the permeability of cell membranes.
It is therefore reasonable to assume that these minerals would also exert an action, either directly, 
or indirectly, on the cardiac cell, on the blood vessel walls, on the blood-pressure-regulating cen-
ters, or on other systems related to cardiovascular function. Astudy showed that the mean values 
of serum   magnesium were lower in patients with acute myocardial infarction than in non cardi-
ac patients. The authors suggested that a lowering or elevation of serum trace elements could be 
useful in the diagnosis of recent infarction and could possibly have other implications [19]. Table 
6 shows  that serum magnesium level was decreased in all patients in comparison  with control 
& this is in agreement with most studies [20]. The disturbances of magnesium metabolism may 
have profound effect on the contractile state of vascular smooth muscle and as a result on blood 
pressure. Accordingly, magnesium is particularly important for assessment of hypertension. [20] 
Reported that magnesium deficiency has a role in the pathogeneses of hypertension.
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The results of this study show that there was a reduction in iron serum level of ischemia with 
diabetes patient and an elevation in patients with ischemia and ischemia with hypertension 
compared with control group. However, these changes were not significant (P>0.05). This was 
explained due to the fact that  ischemic heart diseases, diabetes and hypertension as diseases oc-
curs with variant risk factors mostly not affect the levels of iron if these diseases occur from risk 
factors other than those in the previous points. The results reveal a significant increase p<0.01 in 
serum lead of ischemic heart disease, hypertension and diabetes patients where when compared 
with the corresponding control values. Till (1997), believed that there was no known biological 
requirement for germanium (Ge) which was regarded as not an essential element [21, 22]?  How-
ever, recent study observed that different symptoms in the deficiency of germanium such as 
cardiovascular disease, atherosclerosis, higher risk for several cancers, osteoporosis, and arthritis 
weakened immune system, decreased oxygen [23].
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